SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as its community grapples with mixed sentiments amidst ongoing price stagnation, despite some believing a potential merger involving Zero Hash and Mastercard, alongside progress on the Clarity Act, could be catalysts. Many holders are expressing frustration over consistent declines, while others are actively accumulating, pointing to Flexa's real-world utility with major merchants and recent patents as reasons for long-term optimism. The debate rages between those who see it as a foundational payment collateral token and those who fear it's a 'dead project' that continually disappoints.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is experiencing highly polarized sentiment, with many in the community expressing frustration over significant losses and year-end tax-loss selling contributing to downward pressure. Despite widespread discussions questioning its utility and sustained underperformance relative to other major cryptocurrencies, a dedicated segment of holders maintains long-term conviction, eagerly anticipating a future resurgence.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending with a massive volume surge and price rally following news of a strategic manufacturing partnership aimed at scaling production of its drug screening reader for future U.S. market entry. The community is intensely divided, with bulls pointing to the low float and the positive impact of a $10 million private placement on its balance sheet, while bears express significant concern over dilution, the company's reverse split history, and the offering's terms.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is trending due to massive trading volume and a significant price surge, sparking intense community discussion around its low-float SPAC nature. Traders are actively anticipating further upward movement and a potential squeeze, drawing parallels to other recently explosive micro-cap plays that have experienced rapid ascents.

Alchemy Investments Acquisition Corp. 1 is a blank check company, which engages in merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination. The company was founded on October 27, 2021 and is headquartered in Newark, DE.

Alchemy Investments Acquisition Corp 1 - Ordinary Shares - Class A

Alchemy Investments Acquisition Corp 1 (ALCY) is generating significant buzz as a low-float SPAC, with traders actively discussing its potential for a substantial price run. The community is drawing strong parallels to recent 'shell company rippers' like ESHA, anticipating a considerable upward movement fueled by limited circulating shares and growing speculative interest.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA CRYPTO) is trending due to its new integration with a Stripe-owned fiat anchor, which enables seamless, compliant bank-to-stablecoin transfers at a verified 11 million transactions per second. The community sees it as a potentially undervalued Layer 1 blockchain, poised to become essential financial infrastructure for institutions by offering high-speed, regulated settlement rails. This focus on enterprise-grade plumbing for global finance differentiates it from many other crypto projects.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is experiencing significant upward momentum as the FDA granted Priority Review for its AXS-05 in Alzheimer's disease agitation, with a PDUFA target date of April 30, and confirmed a clear path for its AXS-12 narcolepsy treatment. This major regulatory progress, alongside robust Auvelity sales growth and numerous analyst price target increases, has ignited strong bullish sentiment across the community. Many are celebrating long-term holdings and are optimistic about Axsome's potential to capitalize on substantial market opportunities in CNS disorders.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending with significant community anticipation for the start of a new yearly cycle, driving strong bullish sentiment for substantial long-term gains. Many investors are actively accumulating, citing historical patterns that suggest an imminent upward trajectory. The discussion is marked by strong convictions from bulls, despite ongoing skepticism from bears regarding its immediate outlook.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is trending amid intense community debate, primarily driven by widespread shareholder frustration with CEO Richard Paulson and the board, whom many accuse of continuous value destruction and mismanagement. Recent financing and a reverse stock split, while extending the cash runway, have amplified concerns about dilution and executive accountability. Despite this pervasive negative sentiment toward leadership, significant bullish options activity and anticipation for upcoming Phase 3 trial readouts in Myelofibrosis and Endometrial Cancer highlight an underlying belief in the company's scientific potential, contingent on a change in management.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics (CVKD) is trending due to recent strategic moves, including pipeline expansion through acquisitions and manufacturing advancements for its lead anticoagulant candidate, Tecarfarin. The market is weighing the potential of these developments, including analyst-assigned price targets and FDA designations, against community concerns about cash burn, dilution, and the company's ability to fund pivotal Phase 3 trials. This creates a polarized discussion, highlighting the high-stakes nature of micro-cap biopharma investments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Goldman Sachs began coverage of Stellantis with a ‘Neutral’ rating and said it shares the “attractive value” seen across undervalued premium automakers.</li><li>The firm highlighted sector pressures from Chinese competition, electric-vehicle momentum and tightening European Union rules.</li><li>BMW, Mercedes-Benz, Renault, Ferrari, Volkswagen, Porsche AG and Aston Martin Lagonda were all initiated with varying upside or downside expectations.</li></ul>Stellantis&nbsp;NV offers the same “attractive value” Goldman Sachs sees across Europe’s premium automakers, the bank’s research arm said as it initiated coverage of several carmakers during what it described as “tumultuous times” for the sector. Goldman began coverage of Stellantis with a ‘Neutral’ rating and a $10 price target, implying a 1.3% upside from the last close. The firm said Stellantis shares its valuation appeal, identifying the most undervalued areas of the European auto industry.<h2 class="st-heading-2">Goldman Flags Market Pressure&nbsp;</h2>Goldman said European automakers face growing pressure as Chinese manufacturers expand globally and battery electric vehicle momentum accelerates. The firm added that European Union tariffs, currency swings, and tightening emissions rules are adding further strain. Goldman noted that BMW, Mercedes, Volkswagen and Renault now trade at negative industrial stub valuations, which it called “premature,” and said the premium segment remains the most undervalued part of the market.<h2 class="st-heading-2">Automakers Goldman Sees As Attractive Value Opportunities</h2>Goldman highlighted several automakers that it believes offer meaningful upside. The company initiated BMW with a ‘Buy’ rating and a 112 euro price target, implying a 32% upside. Mercedes-Benz was also initiated with a ‘Buy’ rating and a 74 euro price target, representing a 30% upside. Goldman said it likes both BMW and Mercedes-Benz for their “healthy” balance sheets and “shareholder-friendly” capital allocation frameworks.The bank initiated Ferrari with a ‘Buy’ rating and a $454 price target, giving the stock a 35% upside. Goldman said Ferrari’s higher-priced Special Series volumes support stronger selling prices and growth.Goldman also said Renault offers the same “attractive value” seen across premium automakers. The firm began coverage with a ‘Neutral’ rating and a 36-euro price target, implying a 5% upside.&nbsp;<h2 class="st-heading-2">Automakers Goldman Views More Cautiously</h2>Goldman initiated coverage of Volkswagen with a ‘Neutral’ rating and a 106-euro price target, giving it a 12% upside. Porsche AG was also initiated at a ‘Neutral’ rating with a 46 euro price target, representing a 29% upside.Aston Martin Lagonda received a ‘Neutral’ rating and a 61-pound price target, which reflects a 1% downside. The bank’s research arm highlighted structural concerns over Aston Martin’s balance sheet.<h2 class="st-heading-2">Stocktwits Traders Back Stellantis, BMW, Renault&nbsp;</h2>On Stocktwits, automakers including Stellantis, BMW, Mercedes-Benz, and Renault all saw ‘bullish’ sentiment, though message volume was ‘high’ for Stellantis, ‘normal’ for BMW and Renault, and ‘low’ for Mercedes-Benz.Porsche AG and Aston Martin Lagonda each recorded ‘neutral’ sentiment, with Porsche seeing ‘low’ message volume while Aston Martin registered ‘normal’ activity. Among the outliers, Ferrari drew ‘bearish’ sentiment on ‘low’ message volume, while Volkswagen saw ‘extremely bearish’ sentiment, also amid ‘low’ message volume.So far this year, performance across U.S.-listed European automakers has been mixed.&nbsp;<a href="https://stocktwits.com/symbol/STLA">Stellantis</a> is down 19%, Renault is down 15%, Ferrari is down 8%, and Aston Martin Lagonda is down 38%. Meanwhile, several peers have gained ground, with&nbsp;<a href="https://stocktwits.com/symbol/BMWYY">BMW</a> up 25%,&nbsp;<a href="https://stocktwits.com/symbol/MBGAF">Mercedes-Benz</a> up 26%,&nbsp;<a href="https://stocktwits.com/symbol/VLKAY">Volkswagen</a> up 26% and&nbsp;<a href="https://stocktwits.com/symbol/POAHY">Porsche</a> up 14% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A view of the historical FIAT plant in Turin, Italy. (Photo by Mauro Ujetto/NurPhoto via Getty Images)

Stellantis Stock Joins Undervalued Premium Peers In Goldman’s ‘Attractive Value’ Call Despite Sector Turbulence

The firm highlighted sector pressures from Chinese competition, electric-vehicle momentum and tightening European Union rules.

Equity

Ferrari shares rose&nbsp;over 1% in premarket trading on Friday, recovering some ground after a bruising day, as investors weighed the luxury automaker’s new long-term financial targets and the first look at the technology behind its debut electric car.The Italian carmaker set a 2030 revenue goal of €9 billion, up from a forecast of €7.1 billion for 2025 but below Wall Street’s expectations, along with an adjusted core profit target of at least €3.6 billion. The muted outlook took the shine off the unveiling of the technology behind Ferrari’s first fully electric model, the Elettrica, at its Maranello headquarters.&nbsp;That sent U.S.-listed shares tumbling nearly 15% on Thursday, their worst day since debuting on the NYSE 10 years ago.At the event, CEO Benedetto Vigna called the unveiling “a historic day” for Ferrari, saying the new Elettrica is meant to complement rather than replace its traditional petrol and hybrid cars. The company has also scaled back its electrification goals, now targeting a 2030 lineup comprising 40% internal combustion models, 40% hybrids, and 20% fully electric vehicles, a significant shift from its earlier 2022 target of 40% EVs.The company showcased the Elettrica’s production-ready chassis, featuring in-house battery packs and electric motors developed at Ferrari’s new “e-building.” The completed model, set for a global premiere next year, will reach a top speed of 310 km/h and have a range of at least 530 km. A specially engineered sound system will amplify authentic powertrain vibrations to give the car a distinct “electric Ferrari” identity.In its drive to build a wider lifestyle brand, Ferrari will launch two flagships in London and New York in 2026, with “tailor-made” customization hubs in Tokyo and Los Angeles in 2027. The company also reported that its active customer base has increased by around 20% since 2022 to 90,000.Ferrari continues to trade at premium valuations despite the recent selloff. Its forward price-to-earnings (P/E) multiple has climbed 71.1% over time, pointing to an implied annual growth rate of 5.6%, while peers have contracted: Mercedes-Benz is down 3.7%, Porsche AG has plunged 66.7%, and BMW has declined 20.3%.According to Koyfin, Ferrari’s 12-month average price target suggests a 26.5% upside from its current price of $407.38. Over the past year, the stock has fallen 10.8%. Of 13 covering analysts, three rate it a 'Strong Buy,' five a 'Buy,' four a 'Hold,' and one a 'Sell, giving it an average rating of 3.85 on a five-point scale.Citi noted that Ferrari’s updated 2030 guidance came in below both their own projections and broader market expectations, according to a Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/sustainability/climate-energy/elettrica-ev-launch-marks-ferraris-push-20-electric-lineup-by-2030-2025-10-09/">report.</a>&nbsp;CFRA maintained its 'Sell' rating with a $350 price target—based on a 2026 P/E of 30x versus the company’s 10-year average multiple of 40x, and kept earnings forecasts at €8.80 for 2025 and €10.15 for 2026.&nbsp;The brokerage firm said Ferrari’s 2030 powertrain mix of 40% internal combustion, 40% hybrid, and 20% electric vehicles adds “a high degree of revenue and margin uncertainty,” calling for lower valuation multiples and warning that the strategy could face shareholder pushback.On Stocktwits, retail sentiment for Ferrari was ‘extremely bullish’ amid a 13,100% surge in 24-hour message volume.One user suggested that expectations for Ferrari’s next earnings were already low, adding they would be ready to buy more shares if the stock slipped toward $340.&nbsp;<stembedurl>https://stocktwits.com/wahoowa96/message/631770307</stembedurl>Another described the stock as “a bargain” at current levels.<stembedurl>https://stocktwits.com/Nkhajuria/message/631746352</stembedurl><a href="https://stocktwits.com/symbol/RACE">U.S.-listed shares of Ferrari</a> have declined 3.4% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Photograph of a Ferrari Spider 360 driven in and around Sydney. 6 January 2005. AFR GENERIC Picture by ANDREW QUILTY. (Photo by Fairfax Media via Getty Images via Getty Images)

Ferrari Stock Trots Back Up Premarket After Worst Day Ever: Retail Bulls Hold Their Conviction

The Italian luxury carmaker’s stock continues to trade at premium valuations despite the recent selloff. 

Smart, the joint venture between Mercedes-Benz and China’s Geely, will launch a new two-seat electric vehicle in late 2026 as the successor to its ForTwo city car.The model, called the Smart #2, will be introduced in China, Europe and other overseas markets. It will be a two-door, two-seat vehicle positioned in the A-segment, the company said.The car is being designed by Mercedes-Benz and engineered on a new architecture developed by Smart’s R&amp;D team for ultra-compact models. Production will take place in China.The #2 will join the existing Smart #1, #3 and #5 in the brand’s lineup. Current Smart models in mainland China are priced between 154,900 yuan ($21,700) and 368,000 yuan, CnEVPost&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://cnevpost.com/2025/09/02/smart-2-debut-2026/">reported</a>.Global CEO Tong Xiangbei said developing an ultra-compact EV on a new architecture was more complex than building larger cars, but added that the company was now ready after strengthening its production and development capabilities.The first Smart ForTwo&nbsp;was launched in 1998 and has sold over 2 million cars globally. In 2020, Mercedes-Benz reached an agreement with Chinese automaker Geely to give Smart a fresh start, with the two companies establishing a joint venture in Ningbo, Zhejiang.&nbsp;Under the deal, Mercedes handles the design while Geely takes care of engineering and production.On Stocktwits, retail sentiment for Geely was ‘bullish’ amid ‘low’ message volume.<a href="https://stocktwits.com/symbol/GELYY">Geely’s U.S.-listed stock</a> has risen 37.3% so far in 2025.($1=7.12 yuan)For updates and corrections, email newsroom[at]stocktwits[dot]com.

A smart brand new energy intelligent electric vehicle jointly owned by Mercedes-Benz and Geely Auto Group is displayed inside China's first new energy vehicle block. (Photo credit should read CFOTO/Future Publishing via Getty Images)

Geely And Mercedes To Bring Back Two-Seater Legacy With Smart #2 EV In 2026

The Smart #2 will be designed by Mercedes-Benz, engineered and built by Geely in China, and sold in China, Europe and other overseas markets.

EU nears US trade deal with Airbus exemptions, Ferrari left out - Bloomberg

Investing.com -- The European Union is finalizing a trade agreement with the United States that would protect certain key industries from impending tariffs, with commercial aircraft manufacturer Airbus Group SE (EPA:AIR) set to benefit from exemptions.

German automakers BMW (BMWYY), Mercedes-Benz (MBGAF), and Volkswagen (VWAGY) are in talks with the U.S. over a possible import tariff deal, Reuters <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/autos-transportation/bmw-mercedes-vw-seek-tariff-relief-return-us-investment-handelsblatt-reports-2025-05-28/">reported</a> on Wednesday, citing people familiar with the matter.The automakers are hoping for a deal in June, a source told Reuters while noting that it would rely on the companies pledging substantial investment in the U.S. to convince the administration.Another source told the agency that German automakers would get credits for the vehicles they export from the U.S., which would then be deducted from tariffs as part of the proposal being discussed. None of the companies, however, commented on any talks with the U.S. government.While Mercedes has already said that it will add its best-selling GLC SUV to its Alabama plant lineup starting in 2027, BMW is considering adding shifts at the Spartanburg plant, and Volkswagen's Audi is planning to produce some models in the United States, the report noted.Both BMW and Mercedes also export heavily from the U.S.While Trump previously threatened to impose 50% tariffs on goods from the EU starting June 1, he has since then rolled back on it after a call with the EU Commission chief.The European Commission, which oversees the EU's trade policy, is currently attempting to forge a deal with the U.S. to end import tariffs or prevent further hikes.The region currently faces 25% import tariffs on its steel, aluminium, and cars. All other goods are subject to a 10% tariff.On Stocktwits, retail sentiment around BMW is trending in the ‘bullish’ territory while sentiment around Volkswagen and Mercedes are in the ‘bearish’ and ‘neutral’ territory, respectively.<figure class="image"><img style="aspect-ratio:627/65;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_28_at_2_45_08_PM_png_ef34f669c7.webp" alt="VWAGY's Sentiment Meter and Message Volume as of 2:45 p.m. ET on May 28, 2025 | Source: Stocktwits" width="627" height="65"><figcaption>VWAGY's Sentiment Meter and Message Volume as of 2:45 p.m. ET on May 28, 2025 | Source: Stocktwits</figcaption></figure><figure class="image"><img style="aspect-ratio:628/65;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_28_at_2_46_29_PM_png_38349b6e84.webp" alt="MBGAF's Sentiment Meter and Message Volume as of 2:45 p.m. ET on May 28, 2025 | Source: Stocktwits" width="628" height="65"><figcaption>MBGAF's Sentiment Meter and Message Volume as of 2:45 p.m. ET on May 28, 2025 | Source: Stocktwits</figcaption></figure>Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/boston-scientific-discontinues-worldwide-sales-of-acurate-aortic-valve-systems/ch0oF7wRbsN">Boston Scientific Discontinues Worldwide Sales Of Acurate Aortic Valve Systems: But Retail Sentiment Brightens</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The BMW brand logo can be seen on the hood of a vehicle from the manufacturer in Munich (Bavaria). Photo: Matthias Balk/dpa (Photo by Matthias Balk/picture alliance via Getty Images)

BMW, Mercedes, Volkswagen In Talks With US For Tariff Deal, Says Report

The automakers are hoping for a deal in June, a source told Reuters, while noting that it would rely on the companies pledging substantial investment in the U.S. to convince the administration.

European stocks edge higher as volatile month nears end; earnings in focus

Daimler Truck Q1 sales down 8% as North America, Mercedes segment drop

Here's a deeper look at robotics startup and Apollo-maker Apptronik

Investing.com -- Apptronik, an Austin-based robotics startup, is gaining investor attention as a key player in humanoid robotics, according to Morgan Stanley. 

Which EU companies are leading the fight against climate change

European stocks stable; ceasefire talks, trade tariffs in focus

Mercedes-Benz Group AG engages in the business of manufacturing and distributing premium cars. It operates through the following segments: Mercedes-Benz Cars, Mercedes-Benz Vans, and Mercedes-Benz Mobility. The Mercedes-Benz Cars segment includes the brands Mercedes-AMG, Mercedes-Maybach, and Mercedes-EQ. The Mercedes-Benz Vans segment focuses on selling vans under the Mercedes-Benz brand. The Mercedes-Benz Mobility segment is involved in supporting the sales of the vehicle brands. The company was founded by Gottlieb Daimler and Carl Benz in 1926 and is headquartered in Stuttgart, Germany.

MBGAF
Mercedes-Benz Group AG

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MBGAF News

MBGAFMercedes-Benz Group AG